{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:50Z","timestamp":1707524570757},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,13]]},"DOI":"10.7759\/cureus.26802","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T12:15:38Z","timestamp":1657714538000},"source":"Crossref","is-referenced-by-count":0,"title":["Pathological Femoral Shaft Fracture With McCune-Albright Syndrome With Hyperthyroidism Managed With Oral Alendronate: A Case Report"],"prefix":"10.7759","author":[{"given":"Kuldeep","family":"Bansal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avijeet","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumedha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankita","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubham","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-12","article-title":"McCune-Albright syndrome","volume":"3","author":"Dumitrescu CE","year":"2008","unstructured":"Dumitrescu CE, Collins MT. McCune-Albright syndrome. Orphanet J Rare Dis. 2008, 3:12. 10.1186\/1750-1172-3-12","journal-title":"Orphanet J Rare Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein LS","year":"1991","unstructured":"Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991, 325:1688-95. 10.1056\/NEJM199112123252403","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.1.120","article-title":"Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone","volume":"15","author":"Bianco P","year":"2000","unstructured":"Bianco P, Riminucci M, Majolagbe A, et al.. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res. 2000, 15:120-8. 10.1359\/jbmr.2000.15.1.120","journal-title":"J Bone Miner Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-019-00550-z","article-title":"Fibrous dysplasia of bone and McCune-Albright syndrome: a bench to bedside review","volume":"104","author":"Hartley I","year":"2019","unstructured":"Hartley I, Zhadina M, Collins MT, Boyce AM. Fibrous dysplasia of bone and McCune-Albright syndrome: a bench to bedside review. Calcif Tissue Int. 2019, 104:517-29. 10.1007\/s00223-019-00550-z","journal-title":"Calcif Tissue Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1102-9","article-title":"Best practice management guidelines for fibrous dysplasia\/McCune-Albright syndrome: a consensus statement from the FD\/MAS international consortium","volume":"14","author":"Javaid MK","year":"2019","unstructured":"Javaid MK, Boyce A, Appelman-Dijkstra N, et al.. Best practice management guidelines for fibrous dysplasia\/McCune-Albright syndrome: a consensus statement from the FD\/MAS international consortium. Orphanet J Rare Dis. 2019, 14:139. 10.1186\/s13023-019-1102-9","journal-title":"Orphanet J Rare Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1302\/1863-2548.11.170002","article-title":"Treatment of shepherd's crook deformity in patients with polyostotic fibrous dysplasia using a new type of custom made retrograde intramedullary nail: a technical note","volume":"11","author":"Hefti F","year":"2017","unstructured":"Hefti F, Donnan L, Krieg AH. Treatment of shepherd's crook deformity in patients with polyostotic fibrous dysplasia using a new type of custom made retrograde intramedullary nail: a technical note. J Child Orthop. 2017, 11:64-70. 10.1302\/1863-2548.11.170002","journal-title":"J Child Orthop"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2018-0328","article-title":"Efficacy and safety of bisphosphonate therapy in Mccune-Albright syndrome-related polyostotic fibrous dysplasia: a single-center experience","volume":"25","author":"Wang Y","year":"2019","unstructured":"Wang Y, Wang O, Jiang Y, Li M, Xia W, Meng X, Xing X. Efficacy and safety of bisphosphonate therapy in Mccune-Albright syndrome-related polyostotic fibrous dysplasia: a single-center experience. Endocr Pract. 2019, 25:23-30. 10.4158\/EP-2018-0328","journal-title":"Endocr Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/432060","article-title":"Oral alendronate treatment for severe polyostotic fibrous dysplasia due to McCune-Albright syndrome in a child: a case report","volume":"2010","author":"Arag\u00e3o AL","year":"2010","unstructured":"Arag\u00e3o AL, Silva IN. Oral alendronate treatment for severe polyostotic fibrous dysplasia due to McCune-Albright syndrome in a child: a case report. Int J Pediatr Endocrinol. 2010, 2010:432060. 10.1155\/2010\/432060","journal-title":"Int J Pediatr Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2006.19.s2.583","article-title":"Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome","volume":"19 Suppl 2","author":"Lala R","year":"2006","unstructured":"Lala R, Matarazzo P, Andreo M, Marzari D, Bellone J, Corrias A, de Sanctis C. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome. J Pediatr Endocrinol Metab. 2006, 19 Suppl 2:583-93. 10.1515\/jpem.2006.19.s2.583","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2999","article-title":"Outcome of long-term bisphosphonate therapy in McCune-Albright syndrome and polyostotic fibrous dysplasia","volume":"32","author":"Majoor BC","year":"2017","unstructured":"Majoor BC, Appelman-Dijkstra NM, Fiocco M, van de Sande MA, Dijkstra PS, Hamdy NA. Outcome of long-term bisphosphonate therapy in McCune-Albright syndrome and polyostotic fibrous dysplasia. J Bone Miner Res. 2017, 32:264-76. 10.1002\/jbmr.2999","journal-title":"J Bone Miner Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.06s222","article-title":"Medical therapy in adults with fibrous dysplasia of bone","volume":"21 Suppl 2","author":"Chapurlat RD","year":"2006","unstructured":"Chapurlat RD. Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res. 2006, 21 Suppl 2:P114-9. 10.1359\/jbmr.06s222","journal-title":"J Bone Miner Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(94)90069-8","article-title":"Long-term effects of intravenous pamidronate in fibrous dysplasia of bone","volume":"343","author":"Liens D","year":"1994","unstructured":"Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 1994, 343:953-4. 10.1016\/s0140-6736(94)90069-8","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/101350-pathological-femoral-shaft-fracture-with-mccune-albright-syndrome-with-hyperthyroidism-managed-with-oral-alendronate-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:48Z","timestamp":1707507528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/101350-pathological-femoral-shaft-fracture-with-mccune-albright-syndrome-with-hyperthyroidism-managed-with-oral-alendronate-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.26802","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,13]]}}}